Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Defining biomarkers that predict therapeutic effects and adverse events is a crucial mandate to guide patient selection for personalized cancer treatments. In the present study, we applied a pharmacometabolomics approach to identify biomarkers potentially associated with pathological complete respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Miolo, Gianmaria, Muraro, Elena, Caruso, Donatella, Crivellari, Diana, Ash, Anthony, Scalone, Simona, Lombardi, Davide, Rizzolio, Flavio, Giordano, Antonio, Corona, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129972/
https://www.ncbi.nlm.nih.gov/pubmed/27223427
http://dx.doi.org/10.18632/oncotarget.9489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129972/
https://www.ncbi.nlm.nih.gov/pubmed/27223427
http://dx.doi.org/10.18632/oncotarget.9489

Ejemplares similares